May 3 (Reuters) - Cellect Biotechnology Ltd
* Cellect gets green light from FDA for ApoGraft IND submission in the U.S.
* Cellect biotechnology - U.S. FDA provided Cellect with pre-investigational new drug meeting minutes supporting an IND submission in U.S. for ApoGraft
* Cellect Biotechnology Ltd- submission review included manufacturing (cmc) aspects, pre-clinical data and scope and design of future clinical program. Source text for Eikon: Further company coverage: